<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01043848</url>
  </required_header>
  <id_info>
    <org_study_id>EMSCI-NU-2/09</org_study_id>
    <nct_id>NCT01043848</nct_id>
  </id_info>
  <brief_title>Treatment of Neurogenic Detrusor Overactivity: Early Versus Late Pudendal Nerve Stimulation in Spinal Cord Injury (SCI) Patients</brief_title>
  <official_title>Therapeutic Effects of Early and Late Onset Peripheral Pudendal Neurostimulation on Bladder Function and Autonomic Neuroplasticity in SCI - a Controlled European Multicenter Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ulrich Mehnert</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut Guttmann</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Schweizerisches Paraplegikerzentrum Nottwil</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>BG Unfallklinik Murnau</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Klinik für Paraplegiologie, Universitätsklinikum Heidelberg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Zurich</source>
  <brief_summary>
    <textblock>
      Background: Although a small group, special attention has to be given to lower urinary tract&#xD;
      (LUT) dysfunctions in spinal cord injury (SCI) patients, as they also suffer under a loss of&#xD;
      motor-sensory function and autonomic regulation next to the severe deficiencies in bladder&#xD;
      and bowel control. Autonomic dysregulation linked with LUT dysfunction can cause autonomic&#xD;
      dysreflexia with life threatening increases in blood pressure and there is still no concept&#xD;
      for an early rehabilitation of bladder function after SCI.&#xD;
&#xD;
      Hypothesis: We assume that inadequate reorganization of nerve fibres in SCI is a reason for&#xD;
      spastic bladder dysfunction and vegetative dysregulation and that this can be positively&#xD;
      influenced by early neuromodulation. We hypothesized that bladder dysfunction as well as&#xD;
      autonomic dysreflexia will be positively affected.&#xD;
&#xD;
      Specific aims: Evaluation, if external pudendal nerve stimulation (EPS) can positively&#xD;
      influence LUT rehabilitation in SCI patients and if early initiation of stimulation is more&#xD;
      effective compared to late initiation (after spinal shock).&#xD;
&#xD;
      Experimental design: Prospective multicentre study in 36 SCI patients (24 treatment subjects,&#xD;
      12 control subjects). EPS will be started either within 10 days after SCI (early stim group)&#xD;
      or after cessation of spinal shock (late stim group). Effects on spastic bladder function and&#xD;
      autonomic disinhibition will be assessed by urodynamics, vegetative tests, and by&#xD;
      electrophysiological techniques.&#xD;
&#xD;
      Expected value: If early EPS is effective and complete SCI patients benefit from this&#xD;
      intervention; and if early onset of EPS has better and longer lasting effects than late onset&#xD;
      stimulation, the findings will be of utmost relevance not only for bladder function but also&#xD;
      to alleviate adverse phenomena such as autonomic dysreflexia. Neurostimulation may bear the&#xD;
      opportunity to early reshape maladaptive neuroplasticity. This would be proof of an effective&#xD;
      modulation and promotion of neuroplasticity, thus opening up new treatment options in the&#xD;
      field of paraplegiology.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Poor patient recruitment, necessary number of patients could not be included within the&#xD;
    required time frame&#xD;
  </why_stopped>
  <start_date>December 2009</start_date>
  <completion_date type="Actual">October 2012</completion_date>
  <primary_completion_date type="Actual">October 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Videocystometry</measure>
    <time_frame>week 4, 12, 26, 38, 52 after SCI</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Neurophysiological measurements (NCV, BCR, SSR)</measure>
    <time_frame>week 2, 4, 12, 26, 38, 52 after SCI</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Neurogenic Detrusor Overactivity</condition>
  <condition>Spinal Cord Injury</condition>
  <arm_group>
    <arm_group_label>Early pudendal stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects in this arm will start with the intervention within 2 weeks after SCI</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Late pudendal stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects in this arm will start with the intervention 12 weeks after SCI</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Subjects in this arm will be treated according to standard therapy but will receive no pudendal stimulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>external electric pudendal nerve stimulation</intervention_name>
    <description>intervention timing: twice daily for 20 minutes during 3 consecutive months.&#xD;
intervention procedure: electrodes will be placed around the penile shaft (in males) or clips will be directly placed on the clitoris (in females).&#xD;
intervention device: contic+&#xD;
stimulation parameters: 10 Hz, 200μs pulse width, 10mA (or less, if too uncomfortable).</description>
    <arm_group_label>Early pudendal stimulation</arm_group_label>
    <arm_group_label>Late pudendal stimulation</arm_group_label>
    <other_name>contic+, tic Medizintechnik GmbH, 46286 Dorsten, Germany</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Single event traumatic or ischemic Para- or Tetraplegia&#xD;
&#xD;
          -  Complete SCI (ASIA A)&#xD;
&#xD;
          -  Lesion level between C4 and Th10&#xD;
&#xD;
          -  Performance of study treatment and assessments possible according to the study time&#xD;
             schedule&#xD;
&#xD;
          -  Patient capable and willing of giving written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Nontraumatic Para- or Tetraplegia (i.e. disc herniation, tumor, AV- Malformation,&#xD;
             myelitis) exkl. single event ischemic incidences&#xD;
&#xD;
          -  Pre- known dementia or severe reduction of intelligence, leading to reduced&#xD;
             capabilities of cooperation or giving consent&#xD;
&#xD;
          -  Peripheral Nerve lesions below the level of lesion (i.e. pudendal nerve impairment,&#xD;
             cauda equina syndrome, pre- known Polyneuropathy)&#xD;
&#xD;
          -  Severe craniocerebral injury&#xD;
&#xD;
          -  Previous or planned intradetrusor injections of botulinum toxin&#xD;
&#xD;
          -  Previous or planned surgical therapy for neurogenic detrusor overactivity (e.g.&#xD;
             bladder augmentation, Mitrofanoff, sphincter prothesis, sacral neuromodulation,&#xD;
             deafferentation, sphincterotomy)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ulrich Mehnert, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Zurich</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Martin Schubert, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Balgrist University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Guttmann Institute</name>
      <address>
        <city>Badalona</city>
        <state>Barcelona</state>
        <zip>08916</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Schweizerisches Paraplegikerzentrum Nottwil</name>
      <address>
        <city>Nottwil</city>
        <state>Luzern</state>
        <zip>6207</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Balgrist University Hospital</name>
      <address>
        <city>Zurich</city>
        <zip>8008</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>January 6, 2010</study_first_submitted>
  <study_first_submitted_qc>January 6, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 7, 2010</study_first_posted>
  <last_update_submitted>July 19, 2019</last_update_submitted>
  <last_update_submitted_qc>July 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Zurich</investigator_affiliation>
    <investigator_full_name>Ulrich Mehnert</investigator_full_name>
    <investigator_title>Executive physician</investigator_title>
  </responsible_party>
  <keyword>neurogenic detrusor overactivity</keyword>
  <keyword>neuromodulation</keyword>
  <keyword>spinal cord injury</keyword>
  <keyword>pudendal nerve stimulation</keyword>
  <keyword>videocystometry</keyword>
  <keyword>neurophysiology</keyword>
  <keyword>neuroplasticity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Cord Injuries</mesh_term>
    <mesh_term>Urinary Bladder, Overactive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

